Literature DB >> 6828237

Contrast enhanced brain CT. Comparison between iohexol and metrizoate.

S Holtås, S Cronqvist, T Renaa.   

Abstract

The commonly used contrast medium metrizoate (Isopaque Cerebral) or the new nonionic iohexol were injected intravenously for enhancement of cranial CT in a randomized double blind study. Each group consisted of 105 patients. No serious reactions occurred. Ten patients receiving metrizoate had minor reactions of mainly allergic type, whereas only one patient receiving iohexol reacted. No differences in enhancement efficiency could be observed.

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6828237     DOI： 10.1007/bf00399773

Source DB:  PubMed          Journal:  Neuroradiology        ISSN： 0028-3940            Impact factor:   2.804


  9 in total

1.  Metrizamide in angiography I. Femoral angiography.

Authors:  T Almén; E Boijsen; S E Lindell
Journal:  Acta Radiol Diagn (Stockh)       Date:  1977-01

2.  Iohexol. A non-ionic contrast medium. Pharmacology and toxicology.

Authors: 
Journal:  Acta Radiol Suppl       Date:  1980

3.  Tolerability and usefulness of iohexol in cardioangiography. I. An open multicentre clinical trial.

Authors:  K Levorstad; S Simonsen; M Skrede; O Orning; U Tylén; L Olsson; K Selin; K Dahlström; E Andrew
Journal:  Acta Radiol Diagn (Stockh)       Date:  1982

4.  Clinical testing of Amipaque for cerebral angiography.

Authors:  P Amundsen; G Dugstad; M Slettebö
Journal:  Neuroradiology       Date:  1978-04-27       Impact factor: 2.804

5.  Pain and hemodynamic effects in aortofemoral angiography. Clinical comparison of iohexol, ioxaglate and metrizamide.

Authors:  U Nyman; P Nilsson; A Westergren
Journal:  Acta Radiol Diagn (Stockh)       Date:  1982

6.  Amipaque: a new contrast medium in coronary angiography. Report of a double-blind study in man.

Authors:  I Enge; S Nitter-Hauge; E Andrew; K Levorstad
Journal:  Radiology       Date:  1977-11       Impact factor: 11.105

7.  Cerebral angiography with non-ionic (metrizamide) and ionic (meglumine metrizoate) watersoluble contrast media. A comparative study with double blind technic.

Authors:  I O Skalpe; A Lundervold; K Tjorstad
Journal:  Neuroradiology       Date:  1977-08-25       Impact factor: 2.804

8.  Metrizamide in high-dose urography.

Authors:  A Kolbenstvedt; E Andrew; B Christophersen; K Golman; B Kvarstein; H H Lien
Journal:  Acta Radiol Diagn (Stockh)       Date:  1979

9.  Tolerability and diagnostic usefulness of iohexol in urography. An open multicentre clinical trial.

Authors:  K Levorstad; A Kolbenstvedt; S C Sommerfelt; B E Zachrisson; R Jagenburg; M Egeblad; N Thrane Nielsen; S Sjöberg; J Oldbring; K Sveen
Journal:  Acta Radiol Diagn (Stockh)       Date:  1982
  9 in total
  2 in total

Review 1.  Should nonionic radiographic contrast media be given to all patients?

Authors:  P S Parfrey; B C Cramer; P J McManamon
Journal:  CMAJ       Date:  1988-03-15       Impact factor: 8.262

2.  High-dose contrast-enhanced computed tomography (CECT) with iopamidol in the detection of cerebral metastases. Tolerance of the contrast agent.

Authors:  M Leonardi; A Lavaroni; E Biasizzo; G Fabris; T Penco; F Zappoli
Journal:  Neuroradiology       Date:  1989       Impact factor: 2.804
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.